CureVac Pursues Moderna Over COVID Vaccine Patents

German firm CureVac sues Moderna in Delaware, claiming Moderna's COVID vaccine infringes its mRNA technology patents. Seeks royalties.

#CureVac, #Moderna, #PatentLaw, #MRNA, #COVID19

https://newsletter.tf/curevac-sues-moderna-covid-vaccine-patents/

CureVac has filed a lawsuit against Moderna in Delaware, claiming patent infringement on mRNA technology used in Moderna's COVID-19 vaccine. This action seeks royalties from Spikevax sales.

#CureVac, #Moderna, #PatentLaw, #MRNA, #COVID19
https://newsletter.tf/curevac-sues-moderna-covid-vaccine-patents/

CureVac sues Moderna over COVID vaccine patents in Delaware

German firm CureVac sues Moderna in Delaware, claiming Moderna's COVID vaccine infringes its mRNA technology patents. Seeks royalties.

NewsletterTF

Europe—not US—first to authorize Moderna’s combo mRNA flu-COVID vaccine

Amid RFK Jr.’s anti-vaccine agenda, Moderna withdrew its FDA application last year.

Archive: ia: https://s.faithcollapsing.com/8jbp2

#covid-19 #flu #health #moderna #vaccine
https://arstechnica.com/health/2026/04/europe-not-us-first-to-authorize-modernas-combo-mrna-flu-covid-vaccine/

Europe—not US—first to authorize Moderna’s combo mRNA flu-COVID vaccine Amid RFK Jr.’s anti-vaccine agenda, Moderna withdrew its FDA application last year. Archive: ia: https://s.faithcollapsing.com/8jbp2 https://s.faithcollapsing.com/02lre#covid-19 #flu #health #moderna #vaccine
Europe—not US—first to authorize Moderna's combo mRNA flu-COVID vaccine

Amid RFK Jr.'s anti-vaccine agenda, Moderna withdrew its FDA application last year.

Ars Technica
Europe—not US—first to authorize Moderna's combo mRNA flu-COVID vaccine

Amid RFK Jr.'s anti-vaccine agenda, Moderna withdrew its FDA application last year.

Ars Technica

Europe has authorized Moderna's mCOMBRIAX, the world's first combination mRNA flu and COVID-19 vaccine, for adults 50+. This marks a significant moment for public health and vaccine convenience. However, the US FDA continues to demand more data and has even issued a 'refusal-to-file' letter for Moderna's standalone flu vaccine, highlighting a stark divergence in regulatory approaches that could delay…

https://www.tpp.blog/22fidcz

#technology #moderna #mcombriax

🤖 This post was AI-generated.

La Commissione Europea @[email protected] ha concesso l'autorizzazione all'immissione in commercio per mCOMBRIAX®, il vaccino combinato a #mRNA di #Moderna per la prevenzione dell'influenza e di #COVID-19 nelle persone di età pari o superiore a 50 anni. Ottime notizie per i cittadini! 🧪